Older non-specific immunomodulatory drugs and off-label use of several biologic agents offer treatment options for children with severe atopic dermatitis (AD). However, the future should bring therapies specifically developed for treatment of AD investigated in children.
Newer therapies to treat psoriasis and psoriatic arthritis are more likely to be successful in patients with no prior exposure to biologics. Traditional therapies remain an option but, unlike newer treatments, require monitoring for toxicities.
Resveratrol is a naturally occurring polyphenolic antioxidant found in over 70 plant species. Resveratrol has been demonstrated to extend lifespan and improve healthspan in a variety of animal species.
Although many systemic immunomodulators are approved for psoriasis, their mechanisms of action suggest they have utility in indications ranging from atopic dermatitis (AD) to chronic urticaria. Understanding a systemic immunomodulator’s mechanism of action provides a theoretical basis for uses beyond its labeled indication.
In a study of nearly 5,000 people with and without eczema, researchers have found those with eczema are more likely to have osteoporosis and fractures than adults without the skin condition. Learn more on the study.
Both common and uncommon causes of diaper dermatitis have to be recognized in order to develop an effective plan to treat diaper dermatitis, a condition that is highly frequent in infants, according to a staff physician in pediatric dermatology at the Hospital for Sick Children, Toronto.
Positive results of an open-label, multicenter trial support the use of a gel body wash containing 0.006 percent sodium hypochlorite (CLn Body Wash, Top MD Skin Care) as an adjunct in the management of atopic dermatitis (AD), according to researchers who presented their findings at the 2014 annual meeting of the American Academy of Dermatology.
Vindico Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ (0.25 credits per video). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acute bacterial skin and skin structure infections (ABSSSI) are common across the US, and can range from mild to life-threatening in their severity. This CME program addresses the the current guidelines for optimal diagnosis and management of ABSSSI, as well as potential causes for initial treatment failure and new antibiotics for the treatment of resistant bacterial strains.
This webcast reviews available biologic therapies for psoriatic disease patients.